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Abstract
Background: Migraine aura may be difficult to differentiate from transient ischemic attacks and other
transient neurological disorders in pregnant women. The aims of the present study were to investigate
and diagnose all pregnant women with transient neurological disorders of suspected central nervous
system origin, and to compare this group with a control group of pregnant women with regard to vascular
risk factors and prognosis.
Methods: During a 28 month period, 41 patients were detected with transient neurological symptoms
during pregnancy. These were studied in detail with thorough clinical and laboratory investigations in
order to make a certain diagnosis and to evaluate whether the episodes might be of a vascular nature. For
comparison, the same investigations were performed in 41 pregnant controls. To assess the prognosis,
both patients and controls were followed with questionnaires every year for five years.
Results: Migraine with aura was the most common cause of symptoms during pregnancy, occurring in 34
patients, while 2 were diagnosed with stroke, 2 with carpal tunnel syndrome, 1 with partial epilepsy, 1 with
multiple sclerosis and 1 with presyncope. Patients had more headache before pregnancy than controls, but
the average levels of vascular risk factors were similar. None of the patients or the controls reported
cerebrovascular episodes during the five-year follow-up.
Conclusion: The diagnosis of migraine aura was difficult because for many patients it was their first ever
attack and headache tended to be absent or of non-migraineous type. The aura features were more
complex, with several aura symptoms and a higher prevalence of sensory and dysphasic aura than usual.
Gradually developing aura symptoms, or different aura symptoms occurring in succession as described in
the International Classification of Headache Disorders, seem to be useful for differentiating aura from
other transient disorders. A meticulous history and clinical neurological examination are more useful than
routine supplementary investigations for cerebrovascular disease. The five-year follow-up clearly indicates
that migraine with aura in pregnancy usually has a good prognosis with regard to cerebrovascular events.
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Pregnancy, as well as migraine, are well-known risk factors
for cerebrovascular (CV) episodes (transient ischemic
attacks (TIAs) and stroke). The differentiation of TIAs
from migraine aura in pregnancy is a rather common clin-
ical problem [1]. Both disorders consist of transient neu-
rological phenomena stemming from the central nervous
system (CNS). To complicate the matter, TIAs may be
accompanied by headache [2] and migraine aura often
occurs without ensuing headache (International Classifi-
cation of Headache Disorders, second edition (ICHD-2)
[3], category 1.2.3 Typical aura without headache).
Migraine is particularly common among fertile women,
affecting approximately 20–25% of young and middle
aged women in Europe [4,5]. Although several studies
have shown that migraine improves during pregnancy [6-
8], the migraine worsens in some women [9], and some
women experience their first migraine attack in this
period [10], and particularly migraine with aura (MA)
[11-13].
We have previously reported the occurrence of headache
and transient neurological symptoms in a large cohort (n
= 1,631) of pregnant women based on questionnaires and
interviews [14]. The aim of the present study was, with the
help of thorough clinical and laboratory investigations
and a follow-up, to ascertain the diagnoses for the neuro-
logical symptoms, and the CV risk factors in a sample of
women with symptoms or signs indicative of transient
CNS disorders during pregnancy. We hoped that this
would enable us to formulate guidelines on how to differ-
entiate the two disorders among pregnant women.
Methods
Subject population
There were 41 patients included in the study during the
period from May 1997 to August 1999. The majority, 25
women, were recruited among patients routinely referred
to our department from doctors at the Department of
Obstetrics and Gynecology, and from general practition-
ers. The reasons for referral were transient focal neurolog-
ical deficits where the possibility of migraine aura or CV
or other CNS disorders was present. The remainder was
recruited from a large prospective cohort study on head-
ache and focal neurological symptoms among pregnant
women. This study has been reported previously [14]. In
short, 1,631 pregnant women returned screening ques-
tionnaires at the time of routine ultrasound screening in
week 18 to 20 of the pregnancy about headache and focal
neurological symptoms occurring before pregnancy. Right
after delivery they were asked to return a similar question-
naire about symptoms occurring during the pregnancy;
278 women reported new symptoms of potential focal
neurological character during pregnancy. These were tele-
phone interviewed by a trained doctor in neurology to get
more detailed information about the symptoms. Most of
these women were deemed to have had symptoms due to
disturbances in the peripheral nervous system (for exam-
ple, carpal tunnel syndrome (CTS)) or symptoms of a
non-neurological character. Based on the telephone inter-
view, only 16 (that is, 0.9%. of the total sample) were con-
sidered to have had symptoms indicative of CNS disorder
and were included in the study for further investigations.
All 41 women (the patients) were subjected to a face to
face interview by a trained doctor in neurology and a full
clinical and neurological examination. Most were also
investigated with electrocardiograms, ultrasound of the
precerebral vessels and cerebral magnetic resonance imag-
ing (MRI), as well as extensive blood chemistry screening
for coagulation parameters, hemoglobin (Hb), platelet
count, erythrocyte sedimentation rate (ESR), activated
partial thromboplastin time (APPT), fibrinogen, protein S
and C, lupus anticoagulant and anticardiolipin antibod-
ies, homocystein and antithrombin 3. All MRI investiga-
tions were performed after delivery. As to the other
investigations, in many patients it was not possible for
practical reasons to perform them at the same time as the
symptoms occurred; thus, in some patients they were
done before and in some after delivery. In 16, the blood
samples were taken during pregnancy, and in 25 some
time after delivery.
To obtain a control group for comparison, one control for
each patient (n = 41) was mainly selected from among the
1,631 women in the prospective cohort study without
focal neurological symptoms during pregnancy. The con-
trols were included from November 1998 till April 2000.
The 41 controls were subjected to the same clinical exam-
ination and supplementary investigations as the patient
group except for MRI, and they answered the same ques-
tionnaires. The controls were matched for age and smok-
ing habits, and with regard to whether they had had
deliveries previously or not. For those patients who were
still pregnant while we did the clinical examination, the
controls were also matched with regard to the stage of the
pregnancy. Since the results of several investigations (for
example, lab tests, blood pressure) may be influenced by
pregnancy, investigations in both the case and the control
were performed at the same stage before or after delivery.
All women, both patients and controls, were contacted
once a year for five years after inclusion in the study by
mail containing a questionnaire asking whether they had
contracted any new diseases during the past year, in addi-
tion to questions on headache, aura and medication use
during the past year. The last follow-up study was carried
out in October 2005.Page 2 of 8
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Regional Committee for Ethics in Medical Research, and
the Norwegian Data Inspectorate approved the study.
Data analysis
Comparisons between patients and controls were per-
formed with Wilcoxon matched pairs signed rank test for
continuous variables, and with chi-square test for propor-
tions. P-values ≤ 0.05 are considered statistically signifi-
cant. Data analysis was performed with the Statistical




The final diagnoses for the 41 patients are listed in Table
1. MA was the predominant diagnosis in 34 (83%). In
addition, two patients had CTS, two had stroke (one prob-
ably related to preeclampsia), one had partial epilepsy,
one had multiple sclerosis (MS), and one had presyncope.
In the two CTS patients, entrapment of the median nerve
was verified by neurography. One of the women with CTS
had migraine without aura (MO), but her migraine was
not the cause of the transient neurological symptoms. In
addition, one MA patient also had clinically probable
CTS, but the CTS was not the cause of the neurological
symptoms leading to the referral to a neurologist.
One of the MA patients probably had a minor stroke ten
years before inclusion in the study that had not been
investigated at the time. An MRI scan taken after the preg-
nancy showed signs of an old infarction of the basal gan-
glia area, deemed not to be related to the migraine aura
that occurred during her pregnancy.
The somatic examination was normal in all 41 patients,
with the exception of one patient with hypertension due
to preeclampsia (vide infra), one with a palpable thyroid
gland and one with varices. We found no cases with cervi-
cal bruit or heart murmur.
The likelihood of the focal neurological symptoms
increased through pregnancy among the MA patients was:
In 17%, they occurred during the first trimester, in 32%
during the second trimester, and in 51% during the third
trimester. The mean week of pregnancy for occurrence of
symptoms was similar in those with (n = 34) or without
(n = 7) migraine as a cause (26th versus 22nd week, p =
0.5, Student's t-test).
In the two stroke patients, there was an initial phase with
intermittent symptoms that could have been mistaken for
migraine, but later the diagnosis was relatively evident.
The first woman, 23 years old and previously healthy and
without migraine, started to have headache and intermit-
tent episodes of numbness of the right hand after the 30th
week of pregnancy. In the 34th week the headache
increased in intensity and she developed aphasia and
right-sided hemiparesis that subsided gradually over sev-
eral weeks. Anamnestically, she had several risk factors
(heavy smoking, several close relatives with stroke at an
early age), and she was heterozygous for the Leiden factor
(detected after the stroke). On neurological examination,
there were findings corresponding to the symptoms, and
computer tomography (CT) and MRI showed signs of left-
sided ischemia. Blood chemistry showed increased ESR
(56) and low protein S, and MRI angiogram (including
venous sequence) and Doppler ultrasound examination
showed that pre- and intracerebral vessels were normal.
The second stroke patient was a 33 year old woman in her
fourth pregnancy. Her symptoms started in week 19 with
epigastric pain, daily headache, neck pain, dizziness and
visual obscurations. Two weeks later, she was admitted to
hospital with preeclampsia with severe hypertension
(240/110 mmHg), proteinuria, and somnolence. A CT
scan of the head was normal but the cerebral MRI showed
edema and ischemic lesions of both hemispheres. The
pregnancy was terminated on maternal indication. The
next day she developed paresis of the left hand and was
diagnosed with Gerstmann's syndrome with finger agno-
sia, dyscalculia and left/right confusion. The blood chem-
istry tests revealed that she had pathological values for
homocysteine, antinuclear antibodies (ANA), anticardiol-
ipid antibodies IgG and IgM, lupus anticoagulant and lues
antibodies, proving that she suffered from an antiphos-
pholipid antibody syndrome.
The MS patient, a 23 year old woman in her second preg-
nancy, experienced in the third week of her pregnancy an
episode with numbness of the fifth finger on the right
hand, lasting 2 hours. Ten days later she developed numb-
ness of both soles of her feet, the right leg and pollakisu-
ria, and a subsequent MRI of the head and spinal fluid
examination revealed findings typical of MS.
The patient with epilepsy, a 28 year old woman in her first
pregnancy, experienced several episodes lasting from 10
seconds to 1 minute, often starting with numbness in the
right arm, cheek and sometimes the foot, and then a feel-
ing of remoteness accompanied by dysphasia (mostly sen-
sory, with paraphasia). Partial complex epileptic seizures
were suspected, but electroencephalography (EEG) was
normal, as was brain MRI. She was not treated with antie-
pileptics until four years later when she also developed
attacks with tonic arm movements. This time, EEG
showed epileptic activity in the right temporal area and
she became attack free on lamotrigine.Page 3 of 8
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viously healthy woman without migraine or headache
complaints, experienced 2 episodes with blurring of
vision in the whole visual field, each lasting 10 minutes.
Both episodes occurred when she was standing, and both
subsided quickly when she lay down. She was anemic (Hb
9.5), had no atherosclerotic risk factors except for the
recent delivery, and no other localizing symptoms or
signs.
Migraine diagnoses during pregnancy
With regard to MA subtypes (Table 2), six patients had
probable MA (ICHD-2, 1.6.2), the reason for not having
definite MA being that they had had only one attack, thus
not fulfilling the obligatory criterion of two attacks. Two
of these had only aura without headache. One patient had
probable basilar-type migraine aura, but the headache
phase did not fulfill ICHD-2 criteria of typical MO. Typi-
cal aura with non-migrainous headache (ICHD-2, 1.2.2)
was the most common migraine subtype, and the lack of
accompanying symptoms was the usual reason for not
being able to make a diagnosis of typical aura with
migraine headache (ICHD-2, 1.2.1). One patient convinc-
ingly reported a hemiparesis ipsilateral to sensory symp-
toms. She had no family history of similar attacks and was
classified as sporadic hemiplegic migraine (ICHD-2,
1.2.5).
Special features of the migraine aura during pregnancy
The patient with probable basilar-type migraine had sev-
eral attacks in pregnancy, starting with dizziness followed
by bilateral numbness in both hands and feet and the
head, and then a feeling like she would faint. After ten
minutes she would get a severe throbbing headache with-
out accompanying symptoms. She denied hyperventila-
tion. She had had similar attacks three years before the
pregnancy, but without accompanying headache. An EEG
at that time was normal.
Among the remaining 33 MA patients, sensory aura was
the most common type, occurring in 26 (79%) of them,
thereafter followed by visual aura in 20 (61%) and dys-
phasic aura in 7 (21%). One (2%) also had motor weak-
ness, stating that she could not lift her arm and had
paresis of the foot, in addition to a typical sensory aura.
Only visual aura occurred in 4 patients (12%), only sen-
sory aura in 12 (36%), and only dysphasic aura in none.
A combination of visual and sensory aura occurred in 10
patients (30%), visual and dysphasic aura in 2 (6%), sen-
sory and dysphasic aura in 1 (3%), and visual, sensory
and dysphasic aura in 4 (12%). Most patients (31)
reported that the symptoms lasted less than 60 minutes
per symptom, and 10 patients that the symptoms lasted
less than 15 minutes. Two migraine patients could not
remember the duration of their aura, but could only say
that it had lasted some minutes. In all the others, it had
lasted more than five minutes, as required by the ICHD-2
criteria.
The patients with several symptoms all described a grad-
ual progression from one symptom to another, most com-
monly from visual symptoms to paresthesia. Among the
patients with paresthesia, 16 patients reported a march of
the symptoms, usually starting in the fingers and spread-
ing to the underarm and ipsilateral lower part of the face,
including the mouth. There were 15 patients who experi-
enced positive visual signs, and in 13 of these there was a
gradual progression of the symptoms over more than 4
minutes. Of the 20 patients with visual aura, 6 reported
that the symptoms started within seconds.
In the MA patient who also had clinically probable CTS,
the two disorders were clearly discernible. The migraine
episode started with visual signs and continued with
numbness of the lower two-thirds of the face combined
with numbness of the right arm distal to the elbow. On
later examination, there was numbness of the first, second
Table 1: Cause of transient neurological disorder in 41 pregnant women and pathological findings on supplementary investigations
Diagnosis N (%) Pathological findings with supplementary investigations
Migraine with aura 34 (82.9) MRI: one had signs of a previous stroke (incidental finding), two had unspecific white matter lesions ECG: three 
had right bundle branch block Ultrasound: one had a false positive finding
Stroke 2 (4.8) MRI: two had changes compatible with recent stroke Blood chemistry: one had positive antiphospholipid 
antibodies (IgG and IgS), positive antinuclear factor and lupus and lues antibodies; one had elevated fibrininogen, 
AT3, protein C, and low protein S and APC resistance, and was heterozygous for the factor V Leiden on gene 
testing
Presyncope 1 (2.4) Blood chemistry: anemia
MS 1 (2.4) MRI and cerebrospinal fluid: typical findings for MS
Epilepsy 1 (2.4) EEG: negative first year, later epileptogenic changes
CTS 2 (4.8) Median nerve neurography: pathological in both
APC, activated protein C; AT3, antithrombin 3; CTS, carpal tunnel syndrome; ECG, electrocardiography; EEG, electroencephalography; MRI, 
magnetic resonance imaging; MS, multiple sclerosis.Page 4 of 8
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CTS.
Migraine and aura before and during pregnancy
A detailed interview on headache and aura features allow-
ing accurate diagnosis before and after the start of preg-
nancy was performed only in the patient group.
Retrospectively, migraine attacks prior to pregnancy were
reported by 18 patients, whereof 12 had MA, all of which
included visual symptoms. During pregnancy, however,
visual symptoms were reported by 20 patients. Only 4
patients reported paresthesia before pregnancy, compared
to 26 patients during pregnancy, and speech disturbance
was not reported by any patients before pregnancy, but 7
patients experienced this during pregnancy.
Comparisons of patients and controls
Based on the questionnaires, there was no significant dif-
ference between patients and controls with regard to
headache before pregnancy (Table 3). Neither were there
any significant differences with regard to the presence of
the most common risk factors for vascular disorders
before or during pregnancy (Table 3), with the exception
that the patients had somewhat more previous births than
controls.
The measured variables are shown in Table 4. Since blood
samples were not taken at the same time with respect to
the start of pregnancy, and some also with respect to after
delivery (range of 5–86 weeks after conception, with a
mean of 45 weeks for patients, and 50 weeks for controls),
it is not meaningful to compare the values in the different
diagnostic groups. However, for each patient and control
pair, the blood sample was taken either during pregnancy
or after delivery, and at approximately the same time
before or after delivery. Comparing the patient and con-
trol group (Table 4), patients had significantly higher
systolic blood pressure, Hb, and anticardiolipin IgG anti-
bodies and lower glucose. Systolic blood pressure, Hb and
glucose were significantly different also when the compar-
ison included only patients who had migraine (n = 34,
data not shown), but no significant differences were
found among patient-control pairs when the patient did
not suffer from migraine. Comparing the proportions of
patients and controls with pathological findings, or the
proportions among MA patients and their respective con-
trols, there were no statistically significant findings (Table
4).
In the five-year follow-up study, there were some missing
data. Of the patient group, 1 patient did not answer any
contact, and 3 only answered in the first year, and 35
answered at least once after 4 or 5 years. Of the control
group, all women answered at least once, 1 answered only
the first year, and 39 answered at least once after 4 or 5
years. Of the patients, four developed asthma, two hyper-
tension, one hypothyreodism, and one arthritis. All disor-
ders occurred among the migraine patients. Of the
controls, one woman got asthma and one psoriasis. None
reported CV episodes in either group. The numbers
reporting a new disease were not statistically different
(chi-square test, p = 0.09).
Discussion
The present study clearly shows that MA, definite or pos-
sible, was the dominant cause of transient focal symptoms
or signs during pregnancy, occurring in 34 of the 41
patients (76%). Extensive investigations among the
migraineurs to detect possible CV disease were negative,
and none of them reported CV disorders during the five-
year follow-up. Other causes of transient focal symptoms
were CTS, occurring in two patients as the main cause and
additionally in one in whom migraine aura was the main
cause for referral. Furthermore, there were cases of partial
epilepsy, multiple sclerosis, stroke and (probable) presyn-
cope.
When a patient presents with transient CNS symptoms
during pregnancy, a main concern for the doctor is
whether the episode represents a transient ischemic
attack, heralding a stroke. Therefore, we evaluated rou-
tinely a series of risk factors for CV disease under the
assumption that if a high proportion of the episodes were
of such a nature, the patient group would, in general, have
higher risk factor scores than the control group. In retro-
spect, it appeared that only two patients had CV episodes.
This low prevalence was corroborated by the fact that
patients and controls were rather similar with regard to
risk factors, both self-reported (Table 3) and measured
(Table 4). Although investigations were carried out at the
same stage for each patient and control, some of the sig-
nificant differences between patients and controls may be
explained by the fact that, for some of the patients, the
blood samples or measurements were taken when they
were in the hospital in the acute phase, and they were thus
possibly more stressed (increased pulse and systolic blood
pressure), dehydrated (higher haemoglobin) or had
fasted for a longer time (low glucose). It has also been
shown that high Hb may be a risk factor for migraine and
headache [15], which also may explain the higher Hb lev-
els among patients, the large majority of whom were
migraineurs.
The value of the supplementary diagnostic investigations
in each individual was relatively limited. However, rou-
tine blood samples were useful in the two stroke patients.
In the stroke patient with an antiphospholipid syndrome,
the diagnosis was suspected on the basis of clinical and
increased anticardiolipin IgG and lupus anticoagulant.
The other stroke patient had low protein S and activatedPage 5 of 8
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Leiden, which was confirmed by genetic testing (the
patient was heterozygous for it). A fall in free protein S is
a physiological adaption in a normal pregnancy [16].
Routine MRI was useful for diagnosing stroke and MS, but
in these patients, the clinical course indicated a serious
CNS disorder at a relatively early stage. MRI could also
definitively diagnose a previous minor stroke that had no
relation to the migraine aura in pregnancy. Neurography
was useful for confirming the diagnosis of CTS, but the
clinical distinction from migraine aura was quite easy to
make even in the case with MO and comorbid CTS. Rou-
tine use of Doppler investigation of intra- and precerebral
arteries was not helpful diagnostically in the present
series.
There were probably several reasons why the episodes of
MA seen in this series caused concern about more serious
CNS disorders. Firstly, in many patients it was the first and
only attack, allowing only a probable MA diagnosis to be
made. Secondly, many had typical aura without headache
or with non-migraineous headache, making the migraine
diagnosis less obvious. Thirdly, the aura symptoms
tended to be somewhat atypical, with more patients hav-
ing sensory than visual aura, many having speech prob-
lems, and many having several aura symptoms in
succession. This is in contrast to a previous study in a non-
pregnant unselected population where 70% of MA
patients had visual aura without other symptoms [17].
One can not, however, conclude from the present study
that the aura in pregnant women is different from that of
the general migraine population since most of the
patients in our series were from a highly selected group
referred to a neurologist due to suspicion of a more seri-
ous disorder.
It has previously been convincingly demonstrated that
migraine, and particularly MA, is an independent risk fac-
tor for CV disease, both in young and middle-aged
women [18-21]. The fact that none of the migraine
patients suffered CV episodes during the remainder of the
pregnancy, in the post partum phase or during the five
years of follow-up may serve as additional evidence that
the migraine diagnosis was correct in these patients, and
it also clearly indicates that MA in pregnancy is usually a
Table 3: Questionnaire data for patients and controls
Patient group (n = 41) Control group (n = 41) P-value
Age (years) 28.3 28.9 0.1*
Number of previous births 1.1 0.8 0.02*
Number of previous miscarriages 0.7 0.4 0.1*
Smoking in pregnancy 10 6 0.11†
Smoking before pregnancy 18 15 0.16†
Headache in pregnancy 38 30 0.04†
Headache before pregnancy 36 33 0.5†
Oral contraceptives last year before pregnancy 7 7 1.0†
Hypertension before pregnancy 0 0 1.0†
Hypertension in pregnancy 7 4 0.5†
Previous thromboembolic disorder 0 0 1.0†
Familial hypertension 18 19 0.9†
Angina pectoris 7 7 0.8†
Myocardial infarction 14 10 0.4†
Stroke 10 7 0.5†
Diabetes mellitus 11 13 0.9†
*Wilcoxon matched pairs signed rank test; †Chi-square test.
Table 2: Migraine subtype among patients with transient neurological deficit during pregnancy (based on examination and interview by 
neurologist)
ICHD-2 diagnosis N (%)
1.2.1 Typical aura with migraine headache 9 (26)
1.2.2 Typical aura with non-migraine headache 12 (35)
1.2.3 Typical aura without headache 5 (15)
1.2.5 Sporadic hemiplegic migraine 1 (3)
1.6.2 Probable MA 6 (18)
1.6.6 Probable basilar-type migraine 1 (3)Page 6 of 8
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However, due to the relatively low number of migraine
patients in the present study and the rarity of stroke in this
age group, the present study cannot be taken as evidence
against the previous studies showing that MA is a rela-
tively weak risk factor for stroke.
Several previous smaller studies have indicated that
although migraine in general tends to improve in preg-
nancy, MA is more common and may quite often occur
for the first time during this period. In one study [13], 50–
70% of women with migraine improved during preg-
nancy, but a small proportion (4–8%) experienced wors-
ening of their migraine, particularly those with MA. In
addition, migraine started de novo during pregnancy in
approximately 10% of the cases [22], and the new-onset
migraine was often MA. In another study [23], seven out
of eight pregnant women with focal neurological symp-
toms had headache compatible with migraine, and three
for the first time during pregnancy. It was concluded that
migraine may certainly present in pregnancy for the first
time, particularly MA. Another small study reported that
MA was more common than expected in patients having
migraine occurring for the first time in pregnancy (eight of
the nine patients) [11]. Five of these MA patients had vis-
ual disturbances, five had paresthesia and four had dys-
phasia; these proportions are similar to those in the
present study.
From the present study it is not easy to abstract guidelines
on how to differentiate migraine aura from TIAs in preg-
nancy since there were only two patients with vascular
episodes. In the patient with preeclampsia and malignant
hypertension, the transient visual obscurations that
occurred some weeks before the stroke should not be clas-
sified as a TIA due to brain ischemia. More likely, it was
due to brain edema caused by increased intracranial pres-
sure. The transient episodes in the stroke patients were not
characterized by a gradual progression of the symptom, as
was the case with most of the migraine auras. In addition,
all the migraine patients (except two who could not
remember) had aura lasting more than five minutes. This
may also be useful for differentiating the condition from
TIA, which is often even shorter. Hence, the features that
are highlighted in the ICHD-2 criteria for migraine aura –
a gradual increase in visual and sensory symptoms or a
succession of symptoms over more than five minutes –
seems to be characteristic, at least in the present case
series. Gradual development is not required for the dys-
phasic aura, but in the present series of patients, this never
occurred alone as an aura symptom.
Table 4: Various measurements in patients and controls as means (SD) and number of pathological values
Number with pathological values
Patients Controls Patient group Controls/Mi controls
Pulse 78 (14) 72 (12)* 2 >100 beats/min (1 CTS, 1 Mi) 0/0
Systolic blood pressure 120 (15) 112 (10)† 1 >150 mmHg (stroke) 0/0
Diastolic blood pressure 74 (10) 72 (8) 1 >95 mmHg (Mi) 0/0
Hemoglobin 12.9 (1.1) 12.3 (1.1)† 4 low (all Mi) 10/9 low
Platelet count 250 (74) 249 (63) 1 low (MS), 2 high (stroke, Mi) 2 low, 1 high/2 low, 1 high
ESR 20 (19) 16 (12) 13 high (2 CTS, 1 stroke, 1 PS, 9 Mi) 9/8 high
APPT 27.7 (5.0) 27.6 (2.2) 2 high (stroke, Mi) 0/0
Fibrinogen 3.8 (1.3) 3.5 (0.9) 12 high (1 stroke, 1 PS, 2 CTS, 8 Mi) 8/7 high
Antithrombin 3 112 (15) 108 (15) 1 low (Mi) 3/3 low
Cholesterol 5.4 (1.2) 5.2 (1.3) 5 high (1 CTS, 4 Mi) 3/3 high
Triglycerides 1.5 (1.1) 1.1 (0.8) 6 high (1 CTS, 5 Mi) 3/3 high
Glucose 4.6 (0.5) 5.0 (0.9)* 0 3/2 high
Anticardiolipin ab IgG 0.16 (0.4) 0.03 (0.2) 7 positive (1 stroke, 6 Mi) 1/1 positive
Anticardiolipin ab IgM 0.14 (0.4) 0.05 (0.2) 4 positive (1 stroke, 3 Mi) 3/2 positive
Antinuclear antigen 0.11 (0.3) 0.11 (0.3) 5 positive (1 stroke, 4 Mi) 4/3 positive
Lupus anticoagulant 0.3 (0.2) 0.0 (0) 1 positive (stroke) 1/1 positive
Lues serology 0.3 (0.2) 0.0 (0) 1 positive (stroke) 0/0
Homocysteine 9.9 (6.0) 9.3 (7.3) 6 high (1 stroke, 5 Mi) 1/0 high
Protein C 113 (20) 108 (15) 0 0/0
Protein S 71 (23) 68 (15) 16 low (1 stroke, 2 CTS, 13 Mi) 18/15 low
*P ≤ 0.05; †p ≤ 0.01 (Wilcoxon matched pairs signed rank test). There were no significant differences when comparing the number of pathological 
values between patients and matched controls (n = 41 in each group, chi-square test) or migraineurs and their matched controls (n = 34 in each 
group). Ab, antibodies; APPT, activated partial thromboplastin time; CTS, carpal tunnel syndrome; ESR, erythrocyte sedimentation rate; Mi, 
migraine; MS, multiple sclerosis; PS, presyncope.Page 7 of 8
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The main conclusions of the present study are that MA is
by far the most common disorder underlying transient
CNS symptoms among pregnant women referred to a
neurologist in our setting. Sensory and dysphasic aura,
and aura with several symptoms, or without headache,
seem to be more common in this context than among MA
patients in general. More rarely, similar symptoms may
herald other disorders, like stroke, MS or epilepsy. The
study also documents that the prognosis of MA in preg-
nancy with regard to later CV events tends to be good.
Knowledge of typical migraine aura features combined
with a thorough history and clinical evaluation is usually
sufficient to differentiate migraine aura from other disor-
ders, but blood chemistry for vascular risk factors and
brain imaging studies are useful in cases where there is
still doubt about the diagnosis.
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